Natco Pharma Ltd.

NSE: NATCOPHARM | BSE: 524816 | ISIN: INE987B01026 | Industry: Pharmaceuticals
| Strong Performer, Under Radar
852.7500 -2.80 (-0.33%)
NSE Sep 05, 2025 15:49 PM
Volume: 245.9K
 

logo
Natco Pharma Ltd.
01 Jun 2021
852.75
-0.33%
Ashika Research
Natco Pharma Ltd. (NPL) is a midsized pharmaceutical company with a presence across the pharma value chain. It owns eight manufacturing facilities including six formulations facilities and two API facilities. The company also has a US retail business. Natco is a leading domestic player in the oncology space. NPL's product pipeline consists of drugs,...
Number of FII/FPI investors decreased from 385 to 317 in Jun 2025 qtr
More from Natco Pharma Ltd.
Recommended